Epigenetic Health Monitoring to Reduce Your Future Illness Risk – EP13: Tom Stubbs (Chronomics) – Hyper Wellbeing Innovation Labs, Inc. Blog

In this thirteenth episode, Tom Stubbs, Co-Founder/CEO of Chronomics starts with introducing epigenetics. He describes the technology and expertise that he's brought together to create the only company in the world advancing the forefront of epigenetic biomarkers. He explains how their A.I. based health biomarker engine will be used to reduce your risk of future illness. Thank you for having me on the show. Pleasure to be here and looking forward to chatting with you. Tom: We are very much focused on measuring health so people can avoid disease. Lee: Measuring health so that people can avoid disease, that sounds a little bit cryptic. I mean, essentially we're focused on providing people with objective measures that capture the broader definition of health. So not merely health being the absence of disease, but actually as defined by the World Health Organization over 70 years ago, health being the complete physical, mental and social wellbeing of a person. And we think that this is super important, because with the rise of aging populations and the growth in chronic conditions globally, such as heart disease and type two diabetes, there's a growing need for healthcare to shift towards prevention. And to enable this shift, we need measures to capture the largest risk factors for these conditions ahead of time so that people can prevent through action. Lee: So I think I was one of the first users of Chronomics. I had contacted yourselves at the end of 2018 and took a whole genome sequence and an epigenetic test. We first were putting the product out 2018, and yes, you were among one of the first users of the product. Pleasure to have had you and still have you as a customer, Lee. Lee: And I remember yourselves very favorably, because I was a little bit skeptical because Tommy Woods had informed me that the business model of quite a few companies in the OMIC space is to give you a large questionnaire, apply AI to it, and I've had it demonstrated now to me that based on a simple questionnaire, AI can derive a lot of information about you on the health front, predictive, way more than the OMICS can in some cases. And these companies are doing this heavy OMICS data acquisition, not so much to give you data at the moment, I mean, information, but in order that may be in 5, 10 years, that vast sum of data that can then do something with. And so, I was skeptical at Chronomics maybe doing that, and I said, please make a special case for me. Give me my results without the questionnaire. Tom: Yeah, I do remember this, Lee. And then I said, hey look, if I'm doing a whole genome sequence, I actually want a copy of it. So send me every letter.